Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of TNF-α Inhibitor Reduction or Discontinuation in Patients With Non-infectious Uveitis

NCT05155592 is registered in ClinicalTrials.gov with Dan Liang as lead sponsor.

NCT NCT05155592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05155592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of TNF-α Inhibitor Reduction or Discontinuation in Patients With Non-infectious Uveitis
Lead sponsor
Dan Liang
Phase
Phase 2
Overall status
Unknown status
Start date
January 1, 2021
Completion date
April 1, 2023
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adalimumab, uveitis